Literature DB >> 18437425

Antitrichomonas IgG, IgM, IgA, and IgG subclass responses in human intravaginal trichomoniasis.

Simernjeet Kaur1, Sumeeta Khurana, Rashmi Bagga, Ajay Wanchu, Nancy Malla.   

Abstract

Trichomoniasis, caused by the protozoan parasite Trichomonas vaginalis, is a major nonviral sexually transmitted disease. Clinical spectrum varies from an asymptomatic state to mild, moderate, or severe symptoms. However, the exact factors leading to the variations in symptoms have not been well elucidated. Host's immune response to the parasite may be playing a role in varied symptomatology. The present study reports antitrichomonas IgM, IgA, IgG and its subclasses in doubling dilutions of serum and diluted vaginal washes of six T. vaginalis-infected symptomatic and four T. vaginalis-infected asymptomatic women and uninfected controls by enzyme-linked immunosorbent assay (ELISA). No significant difference was observed in serum IgG ELISA absorbance values from symptomatic compared to asymptomatic subjects (p > 0.05) while a significant difference (p < 0.05) was noted in serum IgM in all the tested dilutions and IgA up to a dilution of 400. This is the first report of the detection of specific IgG subclass response in T. vaginalis-infected female patients, and quantitative analysis of the antibody responses indicated that the production of local IgG particularly IgG1 in vaginal secretions may be playing a significant role in establishing symptomatic infection. The interesting observation of the present study is that the specific IgM was detected in 2 (33.3%) symptomatic and T. vaginalis-infected patients in > or =800 dilutions and in 1 (16.6%) up to 200 dilutions in serum, while it was not detectable in the vaginal secretions of symptomatic patients or in the serum and vaginal secretions of asymptomatic T. vaginalis-infected patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18437425     DOI: 10.1007/s00436-008-0971-y

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  21 in total

1.  The influence of local infection on immunoglobulin formation in the human endocervix.

Authors:  E J Chipperfield; B A Evans
Journal:  Clin Exp Immunol       Date:  1972-06       Impact factor: 4.330

2.  CP30, a cysteine proteinase involved in Trichomonas vaginalis cytoadherence.

Authors:  M R Mendoza-López; C Becerril-Garcia; L V Fattel-Facenda; L Avila-Gonzalez; M E Ruíz-Tachiquín; J Ortega-Lopez; R Arroyo
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

3.  Characterization of Trichomonas vaginalis AP33 adhesin and cell surface interactive domains.

Authors:  J A Engbring; J F Alderete
Journal:  Microbiology (Reading)       Date:  1998-11       Impact factor: 2.777

4.  Antibody to Trichomonas vaginalis in human cervicovaginal secretions.

Authors:  K E Su
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

5.  Evaluation of an enzyme-linked immunosorbent assay for the detection of antibody to Trichomonas vaginalis in sera and vaginal secretions.

Authors:  D A Street; D Taylor-Robinson; J P Ackers; N F Hanna; A McMillan
Journal:  Br J Vener Dis       Date:  1982-10

6.  Trichomoniasis: clinical manifestations, diagnosis and management.

Authors:  H Swygard; A C Seña; M M Hobbs; M S Cohen
Journal:  Sex Transm Infect       Date:  2004-04       Impact factor: 3.519

7.  Antibody in sera of patients infected with Trichomonas vaginalis is to trichomonad proteinases.

Authors:  J F Alderete; E Newton; C Dennis; K A Neale
Journal:  Genitourin Med       Date:  1991-08

8.  Trichomonas vaginalis: evaluating capsid proteins of dsRNA viruses and the dsRNA virus within patients attending a sexually transmitted disease clinic.

Authors:  J F Alderete; K A Wendel; A M Rompalo; E J Erbelding; M Benchimol; T-H Chang
Journal:  Exp Parasitol       Date:  2003 Jan-Feb       Impact factor: 2.011

9.  Reactive nitrogen intermediates in experimental trichomoniasis induced with isolates from symptomatic and asymptomatic women.

Authors:  Nancy Malla; Zarrintaj Valadkhani; Kusum Harjai; Saroj Sharma; Indu Gupta
Journal:  Parasitol Res       Date:  2004-09       Impact factor: 2.289

10.  In vitro comparative kinetics of adhesive and haemolytic potential of T. vaginalis isolates from symptomatic and asymptomatic females.

Authors:  Zarrintaj Valadkhan; Saroj Sharma; Kusum Harjai; Indu Gupta; Nancy Malla
Journal:  Indian J Pathol Microbiol       Date:  2003-10       Impact factor: 0.740

View more
  6 in total

Review 1.  Impact of T. vaginalis infection on innate immune responses and reproductive outcome.

Authors:  Raina N Fichorova
Journal:  J Reprod Immunol       Date:  2009-10-21       Impact factor: 4.054

2.  Molecular characterization of double-stranded RNA virus in Trichomonas vaginalis Egyptian isolates and its association with pathogenicity.

Authors:  Eman K El-Gayar; Amira B Mokhtar; Wael A Hassan
Journal:  Parasitol Res       Date:  2016-06-17       Impact factor: 2.289

3.  Neutrophils kill the parasite Trichomonas vaginalis using trogocytosis.

Authors:  Frances Mercer; Shek Hang Ng; Taylor M Brown; Grace Boatman; Patricia J Johnson
Journal:  PLoS Biol       Date:  2018-02-06       Impact factor: 8.029

Review 4.  Trichomoniasis immunity and the involvement of the purinergic signaling.

Authors:  Camila Braz Menezes; Tiana Tasca
Journal:  Biomed J       Date:  2016-09-21       Impact factor: 4.910

5.  Leukocyte Lysis and Cytokine Induction by the Human Sexually Transmitted Parasite Trichomonas vaginalis.

Authors:  Frances Mercer; Fitz Gerald I Diala; Yi-Pei Chen; Brenda M Molgora; Shek Hang Ng; Patricia J Johnson
Journal:  PLoS Negl Trop Dis       Date:  2016-08-16

6.  Detection of Trichomonas vaginalis in prostate tissue and serostatus in patients with asymptomatic benign prostatic hyperplasia.

Authors:  Jamshaid Iqbal; Jumanah Al-Rashed; Elijah O Kehinde
Journal:  BMC Infect Dis       Date:  2016-09-23       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.